GE Teams With Cloning Company Geron for ESCR

General Electric Company is teaming up with Geron, a biotech firm that engages in human cloning, to form what could be the largest embryonic stem cell research conglomerate. The team wants to use the controversial research to determine whether some medicine are toxic. GE and Geron will use existing embryonic stem cell lines to develop sample human cells that drug companies can use to test the toxicity of new drugs in the development process before animal testing or human trials. "This could replace, to a large extent, animal trials," GE spokeswoman Konstantin Fiedler told Reuters. LifeNews